Enliven Therapeutics
ELVN
#3751
Rank
โ‚ฌ3.12 B
Marketcap
42,42ย โ‚ฌ
Share price
0.26%
Change (1 day)
124.60%
Change (1 year)

EPS for Enliven Therapeutics (ELVN)

EPS in 2026 (TTM): -1,44ย โ‚ฌ

According to Enliven Therapeutics's latest financial reports the company's current EPS (TTM) is -1,52ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,70ย โ‚ฌ an increase over its 2024 EPS that were of -1,72ย โ‚ฌ.

EPS history for Enliven Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,44ย โ‚ฌ-15.14%
2025-1,70ย โ‚ฌ-1.59%
2024-1,72ย โ‚ฌ